NCT07161999Phase 2, phase 3Active not recruiting

Study of COYA 302 for the Treatment of ALS

Study sponsor: Coya Therapeutics

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2027-04Estimated
Enrollment · participants120Estimated
Source updated2026-10-13Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 2 fields changed

Primary completion date changed

Before: Jan 2027. After: Apr 2027.

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source

· 1 field changed

Phase changed

Before: PHASE2. After: PHASE2, PHASE3.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview